查詢結果分析
相關文獻
- Combined Hepatectomy and Hepatic Artery Catheter Implantation and Irinotecan Infusion Is Safe and Effective for Colorectal Cancer with Liver Metastases
- Calcification of Liver Metastases in a Colon Cancer Patient Following Chemotherapy with 5-Fluorouracil: A Case Report
- Suture Granuloma Mimicking Liver Metastasis from Colorectal Cancer on PET/CT
- 大腸癌肝臟轉移的治療
- 大腸癌伴肝轉移經化療合併標靶藥治療後白血球減少症之中醫治療病例報告
- 大腸癌手術的現況
- Metastatic Hepatocellular Carcinoma of Gallbladder with Spontaneous Rupture: A Case Report
- Effect of Vitamin E on Arylamine N-Acetyltransferase Activity in Colon Cancer Tissues
- Adenocarcinoma of the Colon Presenting with a Sister Mary Joseph's Nodule (Umbilical Metastasis)--Case Report
- Effect of 5-Fluorouracil on N-Acetyltransferase Activity in Colon Cancer Tissues
頁籤選單縮合
題 名 | Combined Hepatectomy and Hepatic Artery Catheter Implantation and Irinotecan Infusion Is Safe and Effective for Colorectal Cancer with Liver Metastases=肝動脈導管植入與肝臟切除手術同時進行於大腸癌肝臟轉移病人之治療對於術後肝功能復原之影響 |
---|---|
作 者 | 許至偉; 于家珩; 張子明; 張瀛澤; | 書刊名 | 臺灣癌症醫學雜誌 |
卷 期 | 28:1 2012.03[民101.03] |
頁 次 | 頁18-27 |
分類號 | 416.245 |
關鍵詞 | 大腸癌; 肝轉移; 肝動脈灌注化療; Colorectal cancer; Liver metastasis; Hepatic artery infusion chemotherapy; |
語 文 | 英文(English) |
中文摘要 | 背景:肝動脈灌注化療是用於大腸直腸癌肝轉移的治療選擇之一,因為有較高的局部藥物濃度和較低的全身毒性。這項研究的目的在比較此類患者在接受肝切除的同時一起植 入肝動脈導管帶對於術後肝功能恢復的影響。 方法:以回朔性方法收集到 13 例大腸直腸癌肝轉移的病人,分別接受了大腸肝轉移收到 的肝切除術(組別 1,7 人)或同時再進行肝動脈導管植入術(組別 2,6 人)。肝動脈 導管植入是經胃十二指腸動脈進到肝動脈,他的儲存座則是固定在右下腹壁。在手術前 1 天和手術後的第 1,3,7 天,和 1 年後分別追蹤血清肝功能試驗。採用 Mann-Whitney 方 法來做數據分析,以 P<0.05 認為是有顯著的差異。 結果:平均需要 25.16 分鐘(15-42)來進行肝動脈導管植入。有兩位執行肝動脈導管植 入的病患,因導管移位和阻塞在術後第 2 個月和 6 個月將導管移除。我們分析兩組之間 的血液樣本,他們的肝功能變化沒有表現出顯著的差異。 結論:肝動脈導管植入與肝切除同時進行是安全的選擇。此方式會建議在具有高度肝臟 轉移或覆發風險的患者。 |
英文摘要 | Background: Hepatic artery infusion chemotherapy for colorectal liver metastases is considered to be an important patient treatment option due to higher regional concentration and lower systemic toxicity. This study was conducted to compare the liver function recovery between patients who received liver resection combined with or without hepatic artery catheter implantation. Methods: Our study is based on retrospective data of thirteen patients with colorectal liver metastases who all underwent either hepatectomy procedure (group 1, n = 7) or combined hepatic artery catheter implantation (group 2, n = 6). The hepatic artery catheter was implanted via the gastroduodenal artery to the proper hepatic artery, and the reservoir was fixed in the right lower quadrant abdominal wall. Blood sampling for liver function test was performed on preoperative and postoperative day 1, 3, 7, and year 1. The data were analyzed with Mann-Whitney test and P < 0.05 was considered significant. Results: It needs more 25.16 (15-42) minutes for hepatic artery catheter implantation. There were two hepatic artery catheters removed in the 2nd month and 6th month after operation due to catheter dislodgement and obstruction. We examined the blood samples of the two groups, which showed no significant difference. Conclusions: Hepatic artery catheter implantation combined with hepatectomy for metastatic liver disease is safe and is beneficial in patients who are at a high risk of recurrence. |
本系統中英文摘要資訊取自各篇刊載內容。